Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03217331

CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices

Sponsor: Cardiora Pty. Ltd.

Conditions Left Ventricular Assist Device Right Heart Failure

Interventions CRD-102

Updated 9 times since 2017 Last updated: Jun 24, 2019 Started: Mar 6, 2018 Primary completion: Oct 10, 2018 Completion: May 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03217331, this PHASE1/PHASE2 trial focuses on Left Ventricular Assist Device and Right Heart Failure and remains completed. Sponsored by Cardiora Pty. Ltd., it has been updated 9 times since 2018, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jul 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Recruiting → Completed
Mar 2019 — Jul 2019 [monthly]

Recruiting PHASE1_PHASE2

▶ Show 4 earlier versions

Aug 2018 — Mar 2019 [monthly]

Recruiting PHASE1_PHASE2
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE1_PHASE2
Feb 2018 — Jun 2018 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Aug 2017 — Feb 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cardiora Pty. Ltd.

Data source: Cardiora Pty. Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States